Tongxinluo capsule

DRUG3 trials

Sponsors

yongjun wang, Fudan University, Yanbin Li

Conditions

Cerebral Small Vessel DiseasesIschemic StrokeStent Restenosis

Phase 4

Tongxinluo Capsule in Ischemic Stroke Patients（TISS)

CompletedNCT01919671

yongjun wangIschemic Stroke

Start: 2014-03-31End: 2016-11-30Updated: 2017-01-04

Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study（TOPS-CSVD）

Not yet recruitingNCT06061692

Fudan UniversityCerebral Small Vessel Diseases

Start: 2023-10-31End: 2026-12-31Target: 1052Updated: 2023-09-29

Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting

Not yet recruitingNCT06112028

Yanbin LiStent Restenosis

Start: 2023-10-31End: 2026-11-30Target: 200Updated: 2023-11-01

Related Papers

Tongxinluo capsule in the treatment of cerebral small vessel disease: protocol of a randomised, double-blind, placebo-controlled, multicentre clinical study (TOPS-CSVD)

Stroke and Vascular Neurology2025-09-101 citations

Tongxinluo and Functional Outcomes Among Patients With Acute Ischemic Stroke

JAMA Network Open2024-09-2616 citations